ARMATA PHARMACEUTICALS, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
ARMATA PHARMACEUTICALS, INC. (ARMP) had Lessee, Operating Lease, Liability, to be Paid, Year One of $5.45 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-12
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $5.45M.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $5.45M.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $4.86M.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $5.29M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $5.45M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $5.45M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $4.86M 10-K · filed 2026-03-25 |
| 2025-09-30 | $5.29M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $5.29M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $4.20M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $4.72M 10-K · filed 2025-03-21 |
| 2024-09-30 | $5.14M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $5.31M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $6.54M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $9.90M 10-K · filed 2024-03-21 |
| 2022-12-31 | $2.90M 10-K · filed 2023-03-16 |
| 2021-12-31 | $1.59M 10-K · filed 2022-03-17 |
| 2020-12-31 | $1.64M 10-K · filed 2021-03-18 |
| 2019-12-31 | $1.59M 10-K · filed 2020-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |